LOTUS EYE HOSP & INST L is a Healthcare Services company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 39 | 47 | 48 | 50 | 54 |
| EBITDA (ex other income) | 6 | 8 | 7 | 3 | 3 |
| margin % | 15.0 | 16.1 | 13.6 | 6.9 | 6.3 |
| Owners' profit | 3 | 4 | 3 | 1 | 0 |
| EPS, as reported (₹) | 0.00 | 1.96 | 1.40 | 0.36 | 0.04 |
| ROE % · ROCE % | 5.5 · 7.6 | 7.1 · 9.9 | 4.9 · 6.8 | 1.2 · 2.8 | 0.1 · 1.1 |
| Debt / equity (x) | 0.02 | 0.00 | 0.00 | 0.00 | 0.19 |
| Cash from operations | 4 | 4 | 6 | 5 | 3 |
| Capex | (5) | (3) | (6) | (5) | (13) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13 | 12 | 12 | 14 | 13 | 14 | 14 | 17 |
| Profit before tax | 0 | (0) | 1 | 1 | 0 | (0) | (0) | 1 |
| Net profit | 0 | (0) | 0 | 1 | 0 | (0) | (0) | 1 |
| EPS (₹) | 0.05 | (0.11) | 0.12 | 0.26 | 0.06 | (0.13) | (0.15) | 0.30 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| APOLLO HOSPITALS ENTER. L | 1,27,062 | 60.8 | 12.74 | 33.5 | 20.1 | 16.6 | 19.0 | 16.2 |
| MAX HEALTHCARE INS LTD | 1,00,993 | 69.2 | 9.40 | 44.0 | 13.4 | 11.1 | 27.3 | 27.0 |
| FORTIS HEALTHCARE LTD | 67,025 | 64.0 | 6.59 | 32.9 | 10.5 | 9.7 | 17.8 | 22.0 |
| ASTER DM QUALITY CARE LTD | 39,689 | 124.0 | 8.21 | 40.4 | 8.8 | 8.5 | (11.6) | 14.3 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 1 Sept 2026 · Newspaper notice for 29th AGM and FY2025-26 annual report | compliance | minimal | — | — |
| 1 Sept 2026 · Lotus Eye Hospital FY25-26 Annual Report filed, thin margins persist | results | high | — | — |
| 1 Sept 2026 · 29th AGM on Sept 23 with MD pay hike and director items on agenda | board shareholder meetings | low | — | — |
| 27 Aug 2026 · Lotus Eye Hospital launches Lotus Optique optical store in Coimbatore | business updates | low | — | — |
| 11 Aug 2026 · Lotus Eye Hospital Q1 FY27: Revenue up 26% YoY, net profit at Rs 61.37 lakh | compliance | minimal | — | — |
| 10 Aug 2026 · Lotus Eye Hospital Q1 FY27: Revenue up 26%, PAT rises 13% | results | high | — | — |
| 10 Aug 2026 · Lotus Eye Hospital Q1 FY27 profit rises 13% on 26% revenue growth | results | high | — | — |
| 1 Aug 2026 · Board meeting on Aug 10 to consider Q1 FY27 unaudited results | results | low | — | — |
| 6 Jul 2026 · Routine quarterly dematerialisation certificate filed with depositories | compliance | minimal | — | — |
| 6 Jul 2026 · Routine compliance filing under SEBI Regulation 74(5) for Q1 FY27 | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| GLOBAL HEALTH LIMITED | 38,972 | 70.0 | 9.78 | 39.4 | 13.9 | 13.5 | — | 23.7 |
| NARAYANA HRUDAYALAYA LTD. | 38,213 | 46.5 | 8.42 | 25.4 | 17.8 | 9.2 | 25.0 | 18.8 |
| KRISHNA INST OF MED SCI L | 32,235 | 150.5 | 12.60 | 43.4 | 9.5 | 5.1 | 24.0 | 20.3 |
| DR AGARWALS HEALTH CARE L | 16,043 | 107.9 | 7.57 | 26.2 | 7.9 | 7.1 | — | 28.8 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 1418.8 | 47.3 | 30 of 30 | 0% |
| P/B | 3.9 | 6.2 | 6 of 24 | 78% |
| ROCE | (0.1) | 10.9 | 28 of 30 | 7% |
| ROE | 0.1 | 11.8 | 24 of 24 | 0% |
| Debt / Equity | 0.2 | 0.2 | 11 of 24 | 57% |
| EBITDA margin | 18.5 | 22.0 | 20 of 24 | 17% |
| Revenue growth | 26.2 | 20.2 | 8 of 23 | 68% |
| Profit growth | 12.7 | 8.1 | 9 of 21 | 60% |
| Market cap | 236 | 2415 | 23 of 30 | 24% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
